CCN2: A novel, specific and valid target for anti-fibrotic drug intervention

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 9, 2013, Pages 1067-1071

  Leask, Andrew ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

CCN family; CCN2; Ctgf; Fibrosis; Matricellular proteins; Scleroderma

Indexed keywords

ANTIFIBROTIC AGENT; BLEOMYCIN; CELL PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; ENDOTHELIN 1; FG 3019; GROWTH FACTOR; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

CYTOKINE RELEASE; DIABETIC RETINOPATHY; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; FIBROSIS; GENE OVEREXPRESSION; HEALTH SURVEY; HUMAN; HYPERTROPHIC SCAR; INTRACELLULAR SIGNALING; LUNG FIBROSIS; MEDLINE; MICROALBUMINURIA; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SKIN FIBROSIS; TUMOR MICROENVIRONMENT;

ANIMALS; CELLULAR MICROENVIRONMENT; CONNECTIVE TISSUE GROWTH FACTOR; FIBROSIS; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84882693363     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.812074     Document Type: Review

References (57)

1. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993;327:125-30
2. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-94
3. Ryseck RP, Macdonald-Bravo H, Mattei MG, Bravo R. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 1991;2:225-33
4. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993;4:637-45
5. Holmes A, Abraham DJ, Sa S, et al. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001;276:10594-601
6. Morales MG, Cabello-Verrugio C, Santander C, et al. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J Pathol 2011;225:490-501
7. Igarashi A, Nashiro K, Kikuchi K, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995;105:280-4
8. Wang X, McLennan SV, Allen TJ, Twigg SM. Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes. J Cell Commun Signal 2010;4:15-23
9. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 2005;129:1019-30
10. Wang X, McLennan SV, Allen TJ, et al. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am J Physiol Cell Physiol 2009;297:C1490-500
11. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 2004;279:8848-55
12. Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal 2009;3:89-94
13. Kantarci A, Black SA, Xydas CE, et al. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol 2006;210:59
14. Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996;106:729-33
15. Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38
16. Wenger C, Ellenrieder V, Alber B, et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 1999;18:1073-80
17. Sha W, Leask A. CCN2 expression and localization in melanoma cells. J Cell Commun Signal 2011;5:219-26
18. Shiwen X, Howat SL, Renzoni EA, et al. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem 2004;279:23098-103
19. Kapoor M, Liu S, Huh K, et al. Connective tissue growth factor promoter activity in normal and wounded skin. Fibrogenesis Tissue Repair 2008;1:3
20. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-9
21. Leask A, Holmes A, Black CM, Abraham DJ. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 2003;278:13008-15
22. Chen Y, Shi-wen X, Eastwood M, et al. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum 2006;54:1309-16
23. Van Beek JP, Kennedy L, Rockel JS, et al. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 2006;8:R36
24. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996;7:469-80
25. Liu S, Shi-Wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis. Arthritis Rheum 2011;63:239-46 The first conclusive genetic proof that CCN2 mediates fibrogenesis in vivo.
26. Mori Y, Hinchcliff M, Wu M, et al. Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness. Exp Cell Res 2008;314:1094-104
27. Leask A. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis. Pharmacol Res 2011;63:502-3
28. Shi-wen X, Stanton L, Kennedy L, et al. CCN2 is necessary for adhesive responses to TGF-beta1 in embryonic fibroblasts. J Biol Chem 2006;281:10715-26
29. Mori T, Kawara S, Shinozaki M, et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999;181:153-9
30. Wang Q, Usinger W, Nichols B, et al. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair 2011;4:4
31. Weston BS, Wahab NA, Mason RM. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J Am Soc Nephrol 2003;14:601-10
32. Chen Y, Blom IE, Sa S, et al. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 2002;62:1149-59
33. Kireeva ML, LatinkicBV, Kolesnikova TV, et al. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 1997;233:63-77
34. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999;19:2958-66
35. Chen CC, Chen N, Lau LF. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 2001;276:10443-52
36. Chen Y, Abraham DJ, Shi-Wen X, et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell 2004;15:5635-46
37. Gao R, Brigstock DR. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003;27:214-20
38. Hoshijima M, Hattori T, Inoue M, et al. CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 2006;580:1376-82
39. Ono M, Kubota S, Fujisawa T, et al. Promotion of attachment of human bone marrow stromal cells by CCN2. Biochem Biophys Res Commun 2007;357:20-5
40. Bonniaud P, Margetts PJ, Kolb M, et al. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med 2003;168:770-8
41. Bonniaud P, Martin G, Margetts PJ, et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis- resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004;31:510-16
42. Sonnylal S, Shi-Wen X, Leoni P, et al. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 2010;62:1523-32
43. Wong GS, Rustgi AK. Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer 2013;108:755-61
44. Huang C, Ogawa R. Fibroproliferative disorders and their mechanobiology. Connect Tissue Res 2012;53:187-96
45. Wahab NA, Weston BS, Mason RM. Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 2005;16:340-51
46. Segarini PR, Nesbitt JE, Li D, et al. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 2001;276:40659-67
47. Gao R, Brigstock DR. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003;27:214-20
48. Kawata K, Kubota S, Eguchi T, et al. Role of LRP1 in transport of CCN2 protein in chondrocytes. J Cell Sci 2012;125:2965-72
49. Chen Y, Segarini P, Raoufi F, et al. Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res 2001;271:109-17
50. Cabello-Verrugio C, Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem 2007;282:18842-50
51. Cabello-Verrugio C, Santander C, Cofre C, et al. The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-betadependent signaling, and inhibits TGF-beta-dependent fibrotic response in skeletal muscles. J Biol Chem 2012;287:6773-87
52. Vial C, Gutierrez J, Santander C, et al. Decorin interacts with CTGF/CCN2 through LRr12 inhibiting its biological activity. J Biol Chem 2011;286:24242-52
53. Brandan E, Gutierrez J. Role of proteoglycans in the regulation of skeletal muscle fibrotic response. FEBS J 2013; Epub ahead of print
54. Ponticos M, Holmes AM, Shiwen X, et al. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum 2009;60:2142-55
55. Winkler JL, Kedees MH, Guz Y, Teitelman G. Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy. Mol Vis 2012;18:874-86
56. Adler SG, Schwartz S, Williams ME, et al. Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol 2010;5:1420-8
57. Sisco M, Kryger ZB, O'Shaughnessy KD, et al. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen 2008;16:661-73